No Detail Found!

Intravitreal Injection of lucentis and the vitreomacular relationship in patients with exudative AMD: A prospective study.

Author(s)
Tahir Islam Hull & East Yorkshire NHS Trust, Hull Royal Infirmary, Anlaby Road, Hull, United Kingdom
Salina Siddiqui Hull & East Yorkshire NHS Trust, Hull Royal Infirmary, Anlaby Road, Hull, United Kingdom
Murtaza Mookhtiar Hull & East Yorkshire NHS Trust, Hull Royal Infirmary, Anlaby Road, Hull, United Kingdom
Louise M. Downey Hull & East Yorkshire NHS Trust, Hull Royal Infirmary, Anlaby Road, Hull, United Kingdom
Mark T. Costen Hull & East Yorkshire NHS Trust, Hull Royal Infirmary, Anlaby Road, Hull, United Kingdom
Abstract
Purpose: This study aimed to investigate the relationship between intravitreal injections of Lucentis and the vitreomacular surface. Material and Methods: Central macular thickness (CMT), LogMAR visual acuity and the presence or absence of posterior vitreous detachment (PVD) were noted in Lucentis eligible patients before commencing treatment, and 6 months after initial treatment prospectively. The paired sample t-test repeated measures ANOVA were used. Results: Of 52 eyes analyzed, 70% were noted to have no PVD prior to injection. Of these, 55% of eyes developed PVD. Comparison of the change in CMT between PVD-induced eyes and pre-existing PVD eyes was statistically significant. PVD induction during treatment was associated with a greater reduction in CMT than in eyes with pre-existing PVD. Conclusions: The induction of PVD may have an effect on CMT in eyes injected with Lucentis, implying a potential therapeutic effect of PVD in exudative AMD.
Publication Details
Page(s) 4-8
DOI DOI not available
Published Journal: Pakistan Journal of Ophthalmology , Volume: 31, Issue: 1, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

30

Views